Skip to main content
. Author manuscript; available in PMC: 2012 Jul 26.
Published in final edited form as: Innov Pharm. 2012;3(2):1–11. doi: 10.24926/iip.v3i2.257

Table 1.

Demographic and seasonal influenza vaccine history of survey participants

Items n (%)
Age (n=620)
 < 25 years 124 (20.0)
 25 – 64 years 415 (66.9)
 ≥ 65 years 81 (13.1)

Gender (n=657)
 Male 203 (30.9)
 Female 454 (69.1)

Race/Ethnicity (n=632)
 Caucasian 466 (73.7)
 African American 107 (16.9)
 Hispanic 6 (1.0)
 Asian/Pacific Islander 14 (2.2)
 Native American 10 (1.6)
 Other 29 (4.6)
 Caucasian 466 (73.7)
 Non-Caucasian 166 (26.3)

Estimated Annual Income (n=597)
 Less than $10,000 94 (15.8)
 $10,001 to $25,000 86 (14.4)
 $25,001 to $40,000 153 (25.6)
 $40,001 to $55,000 77 (12.9)
 More than $55,000 187 (31.3)

Highest Education Level (n=647)
 Some high school 27 (4.2)
 High school or GED 145 (22.4)
 Some college 236 (36.5)
 Undergraduate degree 143 (22.1)
 Graduate/professional degree 96 (14.8)

Member of High Risk Group (n=664)
 Yes 313 (47.1)
 No 351 (52.9)

VCU student (n=664)
 Yes 91 (13.7)
 No 573 (86.3)

History of a past seasonal influenza vaccine (n=652)
 Yes 489 (75.0)
 No 163 (25.0)

History of a seasonal influenza vaccine last year (2008) (n=651)
 Yes 375 (57.6)
 No 276 (42.4)